Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs)
$99.04
pos +0.29
+0.29%
Today's Range: 98.69 - 99.65 | JNJ Avg Daily Volume: 8,967,000
Last Update: 04/17/14 - 12:21 PM EDT
Volume: 3,809,600
YTD Performance: 7.82%
Open: $98.69
Previous Close: $98.75
52 Week Range: $82.12 - $99.71
Oustanding Shares: 2,828,901,694
Market Cap: 280,569,741,395
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 6
Moderate Buy 3 3 3 3
Hold 8 6 6 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.19 2.00 2.00 2.12
Latest Dividend: 0.66
Latest Dividend Yield: 2.81%
Dividend Ex-Date: 02/21/14
Price Earnings Ratio: 19.53
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
19.53 20.60 28.65
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.34% 18.35% 63.06%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.16 0.05
Net Income 31.50 0.04 0.01
EPS 24.60 0.01 0.00
Earnings for JNJ:
EBITDA 23.06B
Revenue 71.31B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.52 $1.46 $5.85 $6.31
Number of Analysts 11 10 14 13
High Estimate $1.61 $1.52 $5.95 $6.49
Low Estimate $1.45 $1.41 $5.80 $6.21
Prior Year $1.48 $1.36 $5.52 $5.85
Growth Rate (Year over Year) 2.40% 7.50% 5.89% 8.01%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Apr 16, 2014 | 4:29 PM EDT

We're getting some solid reports, but a lot of people don't want to believe it.

bullishJohnson & Johnson numbers raised at Leerink

Apr 16, 2014 | 8:02 AM EDT

Shares of JNJ now seen reaching $110, according to Leerink Swann. Estimates also increased, given solid pharma momentum. Outperform rating. 

By

Paul Curcio

 | Apr 15, 2014 | 8:55 AM EDT

CPI, Empire index miss mark; Johnson & Johnson beats.

By

James "Rev Shark" DePorre

 | Apr 14, 2014 | 4:15 PM EDT

No leadership, no support and little trust.

updateJohnson & Johnson downgraded at Jefferies

Apr 14, 2014 | 7:57 AM EDT

JNJ was downgraded to Hold from Buy, according to Jefferies. Though co still has strong fundamentals, valuation is too high. $105 price target. 

By

Louis Grasso

 | Apr 8, 2014 | 2:45 PM EDT

Nah. Neither is it sexy, but in the long run it'll do you good.

By

Jared Dillian

 | Apr 8, 2014 | 11:00 AM EDT

I wouldn't buy this market with your money.

By

James "Rev Shark" DePorre

 | Apr 1, 2014 | 4:25 PM EDT

It's a consistent loser.

By

Jim Cramer

 | Apr 1, 2014 | 9:14 AM EDT

Johnson & Johnson is selling its Ortho-Clinical Diagnostics business to The Carlyle Group for $4 billion.

By

Paul Curcio

 | Mar 31, 2014 | 8:30 AM EDT

Update: Futures positive as quarter closes; J&J sells ortho unit.

The owner of the NBA's worst team, the Milwaukee Bucks, has agreed to sell the club for $5...
Good Friday means the markets are closed tomorrow. If you have any April monthly expiratio...
Baker Hughes is trading at new 52 week highs this morning following the company's pre...

I have materially added to my short bond position over this week.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.